Article thumbnail

Additional file 5: of Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review

By Ioannis Christodoulou (312711), Maria Goulielmaki (6062396), Marina Devetzi (6062399), Mihalis Panagiotidis (6062405), Georgios Koliakos (6062411) and Vassilis Zoumpourlis (312715)


Figure S5. Comparison of distribution of anti-cancer effects for naïve MSC vs. naïve MSC used as control cells for genetically modified MSC-based cancer cytotherapy studies (Naïve + GM). Each of the 100% stacked columns shows the relative distribution of anti-cancer effect observed (anti- vs. pro-tumorigenic vs. neutral) (TIF 103676 kb

Topics: Cell Biology, Genetics, Pharmacology, Biotechnology, Developmental Biology, Biological Sciences not elsewhere classified, Adult mesenchymal stem cells, Umbilical cord matrix stem cells, Wharton’s jelly, Tumor microenvironment, Experimental cancer cytotherapy, Gene delivery vehicles
Year: 2018
DOI identifier: 10.6084/m9.figshare.7439750.v1
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.